Skip to main content
Steven Rosenfeld, MD, Neurology, Jacksonville, FL

Steven Samuel Rosenfeld MD

Neurooncology


Professor of Neurology, Cleveland Cl College of Medicine/Case West Res

Join to View Full Profile
  • 4500 San Pablo Rd SJacksonville, FL 32224

  • Phone+1 904-953-2000

Dr. Rosenfeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Neurology, 1986 - 1989
  • Duke University Hospital
    Duke University HospitalInternship, Internal Medicine, 1985 - 1986
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1985

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2027
  • OH State Medical License
    OH State Medical License 2011 - 2026
  • NY State Medical License
    NY State Medical License 2005 - 2022
  • AL State Medical License
    AL State Medical License 1990 - 2005
  • NC State Medical License
    NC State Medical License 1987 - 1998
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Grant Support

  • Generating Synthetic Lethality in Glioblastoma with a First-In-Class Non-Muscle Myosin II InhibitorMAYO CLINIC JACKSONVILLE2025–2029
  • MT-125 for the Therapeutic Treatment of GlioblastomaMYOSIN THERAPEUTICS INC.2023–2025
  • MT-125 for the Therapeutic Treatment of GlioblastomaMYOSIN THERAPEUTICS INC.2023–2025
  • Targeting Go and Grow in GlioblastomaMAYO CLINIC JACKSONVILLE2020–2025
  • Targeting Go and Grow in GlioblastomaMAYO CLINIC JACKSONVILLE2020–2025
  • Targeting Go and Grow in GlioblastomaMAYO CLINIC JACKSONVILLE2020–2025
  • Targeting Go and Grow in GlioblastomaMAYO CLINIC JACKSONVILLE2020–2025
  • Developing nonmuscle myosin II inhibitors for the treatment of glioblastomaUNIVERSITY OF FLORIDA2021–2024
  • Myosin II And Glioma DispersionNational Institute Of Neurological Disorders And Stroke2010
  • Microsystems And Modeling Approach To Glioma Migration And MetastasisNational Cancer Institute2009–2010
  • Mechanisms Of Processivity In Molecular MotorsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2008
  • 2006 Biophysical Discussions - Molecuar Motors: Point CounterpointNational Institute Of General Medical Sciences2006
  • Mechanisms Of Processivity In Molecular MotorsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2005
  • Development Of High Throughput Screening Assays (RMI)National Institute Of Neurological Disorders And Stroke2004
  • Infusion Of Il13-Pe38qqr Cytotoxin In GliomaNational Center For Research Resources2004
  • Molecular Therapeutics For Anaplastic GliomasNational Cancer Institute2002–2003
  • Therapeutic Studies Of Anaplastic GliomasNational Cancer Institute1998–2003
  • Molecular/Cellular Biology Of Glial TumorsNational Institute Of Neurological Disorders And Stroke1997–2001
  • Molecular Motors In NeurooncologyNational Institute Of Neurological Disorders And Stroke1997–2001
  • BCNU PLUS IV Hydroxyurea In Anaplastic GliomasNational Center For Research Resources1998–1999
  • Temozolomide And Procarbazine In Glioblastoma Multiforme At First RelapseNational Center For Research Resources1997
  • 131I Human Monoclonal Antibody Bt32/A6 In Malignant GliomaNational Center For Research Resources1997
  • Temozolomide In Anaplastic Astrocytoma At First RelapseNational Center For Research Resources1996–1997
  • BCNU PLUS IV Hydroxyurea For Anaplastic GliomasNational Center For Research Resources1996–1997
  • Intra Arterial Cisplatin For Newly Diagnosed Anaplastic GliomasNational Center For Research Resources1996
  • Myosins I And II And Cell MotilityNational Institute Of Neurological Disorders And Stroke1994–1995
  • Molecular And Cellular Biology Of Human Glial TumorsNational Institute Of Neurological Disorders And Stroke1994
  • Determinants Of Glioma InvasivenessNational Institute Of Neurological Disorders And Stroke1992–1993
  • Role Of Myosins I And II In Cell MotilityNational Institute Of Neurological Disorders And Stroke1991–1993

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: